HTFL:NASDAQ, Heartflow, Inc.
HTFL stock overview
Heartflow, Inc. (HTFL:NASDAQ) closed at $56.71 on October 23, 2026,
up 2.31% on the day.
The stock trades 1.8% below its 52-week high of $57.74
and 181.7% above its 52-week low of $20.13.
Over the past year, it gained 49.7%.
Heartflow, Inc. is part of the Health Care sector.
Key figures
- Price
- $56.71
- Day change
- +2.31%
- Volume
- 1,533,599
- Average volume
- 1,873,568
- Market cap
- 4B+
- 52-week range
- $20.13 – $57.74
- 50-day average
- $48.87
- 200-day average
- $33.36
Price action over the past year
In 252 trading sessions since October 23, 2025, HTFL closed higher on 131 days (52%).
Its best day was August 14, 2026 (+35.70%) and its worst was February 12, 2026 (-16.55%).
The stock moved 10% or more in a single session 8 times.
It opened at least 5% above the previous day's high 2 times.
Recent signals
HTFL news
-
Oct 23, 2026:
Elucid Statement on Heartflow Lawsuit: Reaffirms Mission, Confidence in Its Technology, and Commitment to Patients and Physicians
-
Oct 19, 2026:
Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026
-
Oct 10, 2026:
Pfizer And 2 Other Top AI Healthcare Stocks
-
Sep 29, 2026:
AI Cardiac Diagnostics Pioneer Sets HeartFlow (HTFL) for High-Margin Expansion
-
Sep 17, 2026:
BCSM Exits Heartflow (HTFL) on Competitive Concerns
-
Sep 15, 2026:
HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High
-
Sep 6, 2026:
HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High
-
Aug 28, 2026:
Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half
About Heartflow, Inc.
Heartflow hs pioneered the use of software and AI to deliver a more accurate and clinically effective non-invasive solution for diagnosing and managing coronary artery disease ("CAD"), a leading cause of death worldwide. As of March 31, 2025, our Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.
Similar stocks
Find more stocks like HTFL with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.